Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Community Environmental Contamination of Toxigenic Clostridium difficile.

Alam MJ, Walk ST, Endres BT, Basseres E, Khaleduzzaman M, Amadio J, Musick WL, Christensen JL, Kuo J, Atmar RL, Garey KW.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofx018. doi: 10.1093/ofid/ofx018. eCollection 2017 Winter.

2.

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin.

Thabit AK, Alam MJ, Khaleduzzaman M, Garey KW, Nicolau DP.

Ann Clin Microbiol Antimicrob. 2016 Apr 12;15:22. doi: 10.1186/s12941-016-0140-6.

3.

Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.

Endres BT, Bassères E, Khaleduzzaman M, Alam MJ, Chesnel L, Garey KW.

Antimicrob Agents Chemother. 2016 May 23;60(6):3519-23. doi: 10.1128/AAC.00211-16. Print 2016 Jun.

4.

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.

Bassères E, Endres BT, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW.

J Antimicrob Chemother. 2016 May;71(5):1245-51. doi: 10.1093/jac/dkv498. Epub 2016 Feb 18.

5.

In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Aitken SL, Alam MJ, Khaleduzzaman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318-23. doi: 10.1017/ice.2015.187. Epub 2015 Aug 20. Erratum in: Infect Control Hosp Epidemiol. 2016 Jan;37(1):124. Khaleduzzuman, Mohammed [corrected to Khaleduzzaman, Mohammed].

6.

Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.

Martinson JN, Broadaway S, Lohman E, Johnson C, Alam MJ, Khaleduzzaman M, Garey KW, Schlackman J, Young VB, Santhosh K, Rao K, Lyons RH Jr, Walk ST.

J Clin Microbiol. 2015 Apr;53(4):1192-7. doi: 10.1128/JCM.03591-14. Epub 2015 Jan 28.

7.

Functional characterization of the heterodimeric sweet taste receptor T1R2 and T1R3 from a New World monkey species (squirrel monkey) and its response to sweet-tasting proteins.

Liu B, Ha M, Meng XY, Khaleduzzaman M, Zhang Z, Li X, Cui M.

Biochem Biophys Res Commun. 2012 Oct 19;427(2):431-7. doi: 10.1016/j.bbrc.2012.09.083. Epub 2012 Sep 20.

8.

Molecular mechanism of species-dependent sweet taste toward artificial sweeteners.

Liu B, Ha M, Meng XY, Kaur T, Khaleduzzaman M, Zhang Z, Jiang P, Li X, Cui M.

J Neurosci. 2011 Jul 27;31(30):11070-6. doi: 10.1523/JNEUROSCI.0791-11.2011.

9.

Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation.

Lewis SD, Butchi NB, Khaleduzzaman M, Morgan TW, Du M, Pourciau S, Baker DG, Akira S, Peterson KE.

J Neurovirol. 2008 Nov;14(6):492-502. doi: 10.1080/13550280802345723.

PMID:
19016073
10.

Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control.

Guan D, Altan-Bonnet N, Parrott AM, Arrigo CJ, Li Q, Khaleduzzaman M, Li H, Lee CG, Pe'ery T, Mathews MB.

Mol Cell Biol. 2008 Jul;28(14):4629-41. doi: 10.1128/MCB.00120-08. Epub 2008 May 5.

11.

Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Khaleduzzaman M, Francis J, Corbin ME, McIlwain E, Boudreaux M, Du M, Morgan TW, Peterson KE.

J Virol. 2007 Nov;81(22):12307-15. Epub 2007 Sep 12.

12.

Epiplakin, a novel member of the Plakin family originally identified as a 450-kDa human epidermal autoantigen. Structure and tissue localization.

Fujiwara S, Takeo N, Otani Y, Parry DA, Kunimatsu M, Lu R, Sasaki M, Matsuo N, Khaleduzzaman M, Yoshioka H.

J Biol Chem. 2001 Apr 20;276(16):13340-7. Epub 2001 Jan 17.

13.

Differential expression of two exons of the alpha1(XI) collagen gene (Col11a1) in the mouse embryo.

Iyama K, Sumiyoshi H, Khaleduzzaman M, Matsuo N, Ninomiya Y, Yoshioka H.

Matrix Biol. 2001 Feb;20(1):53-61.

PMID:
11246003
14.

cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1).

Wu YL, Sumiyoshi H, Khaleduzzaman M, Ninomiya Y, Yoshioka H.

Biochim Biophys Acta. 1998 May 11;1397(3):275-84.

PMID:
9582436
15.

Structure of the human type XIX collagen (COL19A1) gene, which suggests it has arisen from an ancestor gene of the FACIT family.

Khaleduzzaman M, Sumiyoshi H, Ueki Y, Inoguchi K, Ninomiya Y, Yoshioka H.

Genomics. 1997 Oct 15;45(2):304-12.

PMID:
9344653
16.

Ubiquitous expression of the alpha1(XIX) collagen gene (Col19a1) during mouse embryogenesis becomes restricted to a few tissues in the adult organism.

Sumiyoshi H, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Yoshioka H.

J Biol Chem. 1997 Jul 4;272(27):17104-11.

17.

Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1).

Yoshioka H, Iyama K, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Ramirez F.

Dev Dyn. 1995 Sep;204(1):41-7.

18.

Coding sequence and alternative splicing of the mouse alpha 1(XI) collagen gene (Col11a1).

Yoshioka H, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Andrikopoulos K, Ramirez F.

Genomics. 1995 Jul 20;28(2):337-40.

PMID:
8530046
19.

Supplemental Content

Loading ...
Support Center